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Abstract (max 249/250) 
Background  
Men who have sex with men (MSM) are at high risk for sexually transmitted infections (STI) and often 
have sex while under the influence of drugs (sexualized drug use). We aimed to identify subgroups 
of MSM in Amsterdam and in surrounding urban regions with distinctive patterns of sexualized drug 
use and their association with STI. 
 
Methods 
In this cross-sectional study, data on MSM were collected at STI clinics in the Netherlands between 
September-December 2017. Information on drug use, sociodemographics and sexual risk behavior, 
including lab-confirmed STI, -i.e. chlamydia, gonorrhea, syphilis and HIV- was collected and com-
pared between Amsterdam and surrounding urban regions. K-median cluster analysis was used to 




We included 4461 MSM who were median 35 years old(IQR=27-47) and were mostly Dutch (56.9%). 
Use of all drugs were reported more often in Amsterdam compared to surrounding regions 
(p<0.001).  We identified five different subgroups based on sexualized drug use among Amsterdam 
participants and four subgroups in surrounding regions. In both regions, poly-drug use clusters were 
defined by higher numbers of sexual partners (median range 8-15 vs 4-6) and higher STI prevalence 
(range 23.1%-36.2% vs 18.7% - 20.6%) compared to clusters of no drug use or only alcohol use. 
 
Conclusion 
Given the high prevalence of risk behavior and STIs, MSM in urban settings partaking in sexualized 
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drug use combining various drugs might benefit from tailored outreach, screening, and sex and 
drug use interventions. 
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INTRODUCTION 
Compared to the heterosexual population, men who have sex with men (MSM) are more likely to 
use recreational drugs and to engage in sexual activity associated with high risk of contracting sex-
ually transmitted infections (STI)(1, 2). MSM who have sex while under the influence of drugs 
(hence forward sexualized drug use) are known to increase sexual risk behavior, such as condomless 
sex with a human immunodeficiency virus (HIV)-serodiscordant partner and to be at heightened risk 
of contracting STI and HIV (3-9). In particular, chemsex – usually defined as the use of γ-
hydroxybutyrate (GHB)/γ-butyrolactone (GBL), methamphetamine (Crystal Meth) and mephedrone 
during sex – has been described as a major driver of STI/HIV infection(10) and a recent study has 
reported an increase in its use over the last few years(11). Of concern, chemsex is associated with 
drug overdosage, hospitalization for both physical and mental disorders, as well as other societal 
consequences (e.g. unemployment)(12, 13). Reasons for sexualized drug use often described by 
users are: increased sexual arousal, increased sexual confidence and enhanced performance(14, 15).  
In a previous cross-sectional study of MSM in Amsterdam with high-risk sexual behavior, we were 
able to identify five clusters of reported sexualized drug use(16). Based on these clusters, STI preva-
lence was 22.9% among MSM with “polydrug” use, 17.5%-7.6% in clusters with more distinct pat-
terns of drug use (i.e. erectile dysfunction drugs; alcohol and poppers; and alcohol alone), and 1.9% 
in a cluster with no drug or alcohol use during sex. Notwithstanding the potential use of these clus-
ters as a means to identify individuals at risk of STI/HIV, these findings were obtained from cohort 
data of MSM who engaged in an ostensibly higher level of at-risk behavior than MSM in a non-
research setting. Given that Amsterdam is an international metropole with a large MSM communi-
ty, it remains to be determined if similar clustering patterns are also observed in MSM living in ur-
ban regions outside Amsterdam(17-19). Most studies on chemsex have been published on MSM 
residing in cities with large MSM populations, such as London, Barcelona and Manchester(1, 4, 5, 7-
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9, 13-16)  Therefor, the types and characteristics of drug use could be different in urban settings 
with smaller MSM populations. These differences could have implications on the effectiveness of 
interventions aimed to minimize harm related to sexualized drug use and allow for tailored ap-
proaches and test policies in different urban settings.  
 
The aims of this study were (1) to assess differences in sexualized drug use among MSM in Amster-
dam and surrounding urban regions (2) to assess patterns in sexualized drug use, as determined by 




Study design  
In the Netherlands, STI clinics managed by public health services (PHS) provide STI testing 
services anonymously and free of charge. Demographics and sexual behavior data are routinely 
collected. Data from 24 clinics covering all regions of the Netherlands are merged into a cen-
tralized, nation-wide database by the National Institute of Public Health and the Environment 
(RIVM). 
 
In this cross-sectional study, data were restricted to MSM attending Dutch STI clinics for three 
consecutive months between September-December 2017. During this period, additional data 
on drug use were collected.  Ethical approval for the study was not necessary following Dutch 
law, as the study used routinely collected, de-identified surveillance data. 
 
Data collection and definitions 
Socio-demographic characteristics and information on sexual behavior and other STI risk fac-
tors in the preceding 6 months were routinely collected, including number of partners, being 
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notified by a sex partner or having STI-related symptoms. MSM were defined based on self-
declared sexual behavior (having had sex with a man in the last 6 months). STI screening in-
cluded nucleic acid amplification testing (NAAT) for Chlamydia trachomatis and Neisseria 
gonorrhoeae at three anatomical locations (pharyngeal, urethral and anorectal) and serum test-
ing for syphilis and HIV. 
 
Data on drug use were collected either via computer-assisted self-interviewing or during con-
sultation by a health care professional. All MSM were asked if they used drugs or were inebri-
ated before or during sex in the past 6 months and if so, which drugs they used from a prede-
fined list. This list included the following substances: alcohol, amphetamine (speed), cannabis, 
cocaine, GHB/GBL, ketamine, methamphetamine (crystal meth), mephedrone, nitrites, 3,4-
methylenedioxy-N-methylamphetamine (XTC/MDMA) or other drugs. Any drug use was de-
fined as self-declared use of at least one of the drugs mentioned above, including alcohol, with-
in the past six months.  
 
Educational level was divided into low (primary school and lower secondary vocational educa-
tion), medium (intermediate secondary general education, higher secondary general educa-
tion, senior secondary vocational education and pre-university secondary education) or high 
(higher professional or university education). Ethnicity was defined according to Statistics 




To prevent reporting bias from centers with excessive missing data, only STI clinics where more 
than 90% of visitors had data on drug use were included. We then defined two geographical regions 
based on testing centers with available data: Amsterdam and surrounding urban regions (all STI 
Versie 1.6 Pagina 8 
clinics outside the Amsterdam region). Participant characteristics were described and compared 
between those from Amsterdam versus surrounding urban regions. For individuals with more than 
one visit during the study period, any visit after the initial visit was excluded.  
 
To define drug use clusters, we employed a k-medians clustering algorithm with the Jaccard similar-
ity measure (specified for binomially distributed data)(21) using the ‘flexclust’ package in R(22). The 
optimal number of clusters, k=(2, 3, …, 10), was based on maximizing the Caliński and Harabasz 
pseudo-F index (with larger indices representing more distinct clustering). The reproducibility of the 
clustering method was tested by repeating the k-median segmentation algorithm on 50 boot-
strapped dataset replicas and calculating the adjusted Rand indices (measuring the similarity of the 
clusters from bootstrapped data to those obtained from the original data)(23). The final choice of k 
was determined by a high Caliński and Harabasz pseudo-F index and high density peak of boot-
strapped adjusted Rand indices. After defining k, cluster groups were assigned to each observation 
based on the similarity measure above, meaning that every individual in the analysis was classified 
into one of the identified clusters.   
 
Correlations between drugs used were determined using tetrachoric correlations and visualized in 
networks using Cytoscape v3.6.1 (24).  
 
Demographic characteristics, sexual behavior and STI prevalence were compared between the 
identified cluster groups. All comparisons were tested using Pearson’s χ² test for categorical varia-
bles and rank-sum tests for continuous variables, unless specified otherwise. In sensitivity analysis 
we repeated cluster analysis without MSM who were notified by a sex partner or had STI related 
symptoms. Moreover, multinomial logistic regression was used to correct STI prevalence for age, 
ethnicity and HIV-status. 
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Statistical analyses were performed with STATA Intercooled 13.1 (STATA Corporation, College Sta-
tion, TX, USA) and R (v3.4.1, R Foundation for Statistical Computing, Vienna, Austria). Significance 




Description of the study population 
Between September 2017 and December 2017, 11300 consultations involving MSM were recorded. 
Five centers recorded >90% data on drug use (mean 99.6%, range=98.9%-100%). The other 19 cen-
ters had a mean 45.9% (range=28.8%-76.5%) of consultations with available drug use data and were 
excluded. This resulted in 5060 of 11300 (44.8%) consultations performed at included centers. We 
excluded 582 repeat visits during the study period and 17 visits without data on drug use. Thus, 4461 
MSM were analyzed: 3201 from the Amsterdam PHS and 1260 from PHS in surrounding urban re-
gions (Flevoland, Hollands Noorden, Den Haag and Utrecht).  
 
Participant characteristics are summarized in Table 1. The overall median age was 35 years (IQR=27-
47), 43.1% were of non-Dutch ethnicity and 64.6% had a high educational level. In Amsterdam, par-
ticipants were more often known to be HIV-positive (19.0% vs 8.3%, p<0.001) than in the surround-
ing urban regions and reported less often having sex with both women and men (8.3% vs 20.0%, 
p<0.001). STI prevalence did not differ per region (22.3% in Amsterdam vs 21.4% in the surrounding 
urban regions, p=0.540). Of the 3714 individuals without a previous HIV-positive diagnosis, 32 
(0.9%) were newly diagnosed with HIV.  
 
Description of drug use 
In total, 2445/4461 (54.8%) participants reported sexualized drug use in the preceding 6 months and 
234 (5.3%) of whom reported using 5 types of drugs or more. For each drug, a higher proportion was 
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used in Amsterdam than in the surrounding urban regions (p<0.001 for all). Alcohol was most often 
reported respectively in Amsterdam vs surrounding urban regions (42.9% vs 28.6%), followed by 
XTC (20.2% vs 14.1%), GHB/GBL (17.7% vs 10.2%) and nitrites (19.3% vs 8.3%). Methamphetamine 
(3.1% vs 0.8%) and mephedrone (1.9% vs 0.5%) were the least frequently reported drugs.  
 
Patterns of drug use in Amsterdam and surrounding urban regions 
In Amsterdam, we distinguished five distinct clusters of drug use (Figure 1a). The first cluster 
(n=1287, 40.2%) included MSM reporting no or sparse drug use, which was defined herein as “no 
drug” users. The second cluster (n=732, 22.9%) consisted of MSM reporting use of mainly alcohol 
(“alcohol” users). In the third cluster (n=469, 14.7%), MSM reported use of mostly alcohol, cannabis 
and nitrites (“alcohol and soft drugs” users), while MSM in the fourth cluster (n=380, 11.9%) report-
ed mainly XTC, GHB/GBL and alcohol (“XTC, GHB/GBL and alcohol” users). MSM in the fifth cluster 
(n=333, 10.4%) reported use of several drugs, including GHB/GBL, nitrites, ketamine, cocaine and 
methylamphetamine, but relatively low levels of alcohol use (“polydrug” users). Correlation net-
work demonstrated low correlations between alcohol, cannabis and other drugs, but relatively high 
correlations between ketamine, GHB/GBL and XTC. (Figure 1b).  
 
In the surrounding urban regions, four distinct patterns of drug use emerged (Figure 2a). The first 
cluster (n=732, 58.1%) consisted of MSM showing no sexualized drug use (“no drugs” cluster), while 
the second cluster (n=306, 24.3%) consisted of MSM using mainly alcohol (“alcohol” cluster). MSM 
in the third cluster (n=94, 7.4%) reported use of a broad range of drugs, including cocaine, XTC and 
GHB/GBL, but was mostly defined by high use of nitrites and alcohol (“polydrug and poppers”). In 
the fourth cluster (n=128, 10.2%), MSM reported high use of GHB/GBL and XTC (“GHB/GBL and 
XTC” cluster). Correlation network analysis again demonstrated relatively high correlations between 
ketamine, GHB/GBL and methylamphetamine but also between cocaine and amphetamine (Figure 2b).  
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In a sensitivity analysis, excluding MSM visiting STI clinics with symptoms or after a partner notification 
rendered comparable results (data not shown). 
 
Association of drug-use clusters with sexual behavior and STIs in Amsterdam and surrounding 
urban regions. 
In Amsterdam, demographic characteristics, sexual behavior and STI prevalence are reported per 
cluster in Table 2. Compared to “no drug” users, “polydrug” users were more often of Dutch ethnici-
ty (62.2% vs 49.7%, p<0.001) and reported more sexual partners in the preceding 6 months (median 
15, IQR=6-30 vs. 5, IQR=3-10, p<0.001) and lower condom use during the last sex act (76.7% vs 
59.9%, p<0.001). “Alcohol” users were younger (p<0.001) and more often HIV negative (p<0.001) 
compared to MSM in other clusters. 
 
“Polydrug” users had the highest proportion diagnosed with an STI (27.3%), which was significantly 
higher compared to “no drug” users (20.6%, p=0.008) or “alcohol” users (20.3%, p=0.010), but not 
significantly different from “alcohol and soft drugs” (23.1%, p=0.175) or “XTC, GHB/GBL and alco-
hol” users (26.6%, p=0.822). No differences in proportion with newly diagnosed HIV were found 
between clusters (p=0.870). Differences in STI prevalence remained when adjusting for age, HIV-
status and ethnicity (see appendix figure 1a).  
 
In the surrounding urban regions, as shown in Table 3, MSM in the “GHB/GBL + XTC” cluster report-
ed the highest number of sexual partners (median 10, IQR=5-15). This was significantly higher than 
those in the “no drugs” (median 4, IQR=3-8, p<0.001) and “alcohol” clusters (median 5, IQR=3-8, 
p<0.001) but not significantly higher than those in the “polydrug and nitrites” cluster (median 8, 
IQR=4-16, p=0.667). MSM in the “alcohol” cluster were younger (median age 28, IQR=23-35) than 
those in other clusters (median age 37, IQR=26-49, p<0.001). 
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STI prevalence differed significantly across clusters and was highest in the “GHB/GBL + XTC” cluster 
(36.2%) and lowest in the “no drugs” cluster (18.7%). Of note, more newly diagnosed HIV infections 
were found in the “GHB and XTC” cluster compared to the “no drugs” cluster (3.8% vs 0.4%, 
p=0.001).  Differences in STI prevalence were similar when adjusting for age, HIV-status and ethnici-




Using a large database of STI clinic visitors across the Netherlands, we identified five distinct pat-
terns of drug use in Amsterdam and four patterns in surrounding urban regions. In both regions, 
MSM belonging to clusters involved in low levels of drug use (“no drugs” clusters) or only alcohol 
use (“alcohol” clusters) reported lower sexual risk behavior and were less likely to be diagnosed with 
an STI compared to MSM belonging to other clusters. MSM in clusters established on the use of a 
combination of different drugs (“Alcohol + poppers”, “Polydrug and Poppers”, “Polydrug”, “XTC + 
GHB + Alcohol” and “GHB + XTC” clusters) reported higher number of sexual partners and had a 
higher proportion with detected STIs. 
 
Importantly, we demonstrate that drug use during sexual activity is common among MSM, with 
54.8% reporting having used drugs during sex in the preceding 6 months. Examining previous data 
of MSM at the STI clinic in Amsterdam from 2008-2009, use of GHB/GBL, XTC, and cocaine were 
similar to our study, but use of nitrites and cannabis were substantially lower compared to the cur-
rent analysis (38.3% to 19.3% for nitrites and 21.1% to 12.7% for cannabis)(5). This is in contrast to 
Sewell et al who found an increased use of GHB/GBL from 13.1% to 19.8% between 2013 until 2016 
in the UK(11). The discrepancy between studies could be explained by geographical location, the 
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already relatively high levels of drug use in Amsterdam(9) or a possible recruitment bias as study 
locations gained awareness as chemsex support centers over time(11).  
 
We noticed marked differences in sexualized drug use between Amsterdam and the surrounding 
urban regions.  Drug use is much more common in Amsterdam than in the surrounding urban re-
gions, hence the importance of stratifying cluster analysis on these regions. Indeed, there were 
similarities in identified clusters, namely no drug use and only alcohol use. Nevertheless, we did 
observe nuances in polydrug use when comparing regions. In Amsterdam, more diverse subgroups 
were identified with different combinations, while in the surrounding urban regions, polydrug use 
seemed to be limited to a combination of specific drugs, like nitrites, GHB/GBL and XTC. Moreover, 
in the surrounding urban regions, some of the clusters from Amsterdam were not observed, particu-
larly ‘alcohol and poppers’ and ‘GHB+XTC’ clusters. The reasons for such regional differences are 
difficult to explain. Possibly, the role of peers and partners, along with positive norms for drinking 
and drug-taking, could shape individual patterns of use, which could be further enhanced by struc-
tural or environmental proximity for excessive alcohol and illicit drugs(14, 25)   these external fac-
tors could play out differently within regions.  
Previous research has consistently identified groups of MSM engaging in polydrug use(6, 7, 16, 26). 
Some of these studies have also linked polydrug use to sexual behavior(7) or STI prevalence, either 
self-reported(6) or laboratory-confirmed(16). We add to these previous studies by demonstrating 
the link between a broad range of clusters and sexual behavior. Although different clusters of 
“polydrug” use were uncovered between Amsterdam and surroundings, its association with STI 
prevalence was maintained in both regions. It is generally considered that ‘chemsex’, one of the 
more common forms of polydrug use, is the hallmark of increased STI risk(27). Our data would con-
tend that STI risk could lie outside the definition of ‘chemsex’ and could be quite high even among 
individuals using other combinations of drugs, particular in non-metropolitan settings.        
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Public health interventions, such as pre-exposure prophylaxis against HIV in MSM, are soon to roll 
out in the Netherlands and based on Dutch recommendations, would coincide with STI screening 4 
times a year(28). As increasing demand for STI associated care in the Netherlands could be likely, 
increasing healthcare costs warrant more efficient methods for screening(29). Targeting interven-
tions, particularly among individuals with specific profiles of drug use, could be helpful; however, 
given that STI prevalence was at 18.7%-20.6%% in the no drug use clusters, other factors would 
likely be needed to identify MSM at high-risk of having an STI. In addition, the polydrug clusters 
express the need for STI clinics to collaborate with specialized drug dependency services in order to 
offer a more appropriate response for the complex needs of some clients.  
 
Several limitations of our study need to be mentioned. First, we recognize this study is not repre-
sentative for all MSM in the Netherlands, both due to missing data of the remaining STI centers and 
of MSM not attending STI clinics. MSM in the overall population might show lower sexual risk and 
drug-use behavior. Second, our previous analysis in high-risk MSM from Amsterdam demonstrated 
a cluster with high levels of EDD use combined with medium levels of nitrites(16). Since information 
on EDD use was not collected in the presented database, we were unable to further elaborate the 
role of these drugs in our study population. Third, data on frequency of use, drug dependency and 
drug-related harm were lacking. Nevertheless, previous research has suggested low levels of de-
pendency for GHB/GBL, mephedrone, and methyl amphetamine in Amsterdam(1). Lastly, the in-
tent of drug use was not asked, as some studies define chemsex as intentionally using drugs to facil-
itate or enhance sexual encounters(8, 15). Its association with behavioral or prevalent STI could be 
rather different. Despite these limitations, our study is one of the first with detailed epidemiologic 
and behavioral data within the context of a national network of STI clinics, enabling us to compare 
different geographical regions. This framework also allowed us to include laboratory confirmed 
STIs, whereas many other studies rely on self-reported STI or only on sexual behavior(4, 6, 7, 9). 
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Since drug policies are liberal in the Netherlands compared to other countries, drug use might be 
more openly discussed, making underreporting less likely in our study population(30).   
 
In conclusion, several patterns of sexualized drug use among MSM were identified, with noticeable 
differences between Amsterdam versus surrounding urban areas. These drug use patterns were 
closely linked to sexual behavior and STI prevalence. Clusters involving polydrug use, be it in specif-
ic combinations or widely varying drugs, were consistently associated with prevalent STIs in both 
regions. STI risk could be quite high even among individuals using other combinations of drugs than 
the definition of ‘chemsex’, particularly in non-metropolitan settings. Nevertheless, further research 
is required to determine how these clusters could be used to identify individuals for tailored drug-
based STI screening and prevention programs. 
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Tables and figures 
Table 1. Demographics, sexual behavior, sexual transmitted infections (STI) and drug use of 4461 MSM 
visiting STI clinics in Amsterdam and surrounding area’s (Sept-Dec 2017) 











  n %*  n %*    
Age (years)          
Median [IQR]  36 [28-47]  33 [25-47]  <0.001  
Ethnicity        <0.001  




   




   
Educational level a         <0.001  




   




   
HIV-status b        <0.001  
Positive   608 19.0%  105 8.3%    
  Negative  2593 81.0%  1155 91.7%    
Reason for consultation          
Notified of an STI  734 22.9%  235 18.7%  0.002  
STI-related symptoms   685 21.4%  204 16.2%  <0.001  
Sexual partners        <0.001  
Men only  2934 91.7%  1008 80.0%    
Both men and women  267 8.3%  252 20.0%    
 Median number of sex partners c        <0.001  
Median [IQR]  7 [4-15]  5 [3-10]    
Condom use during last sex act        0.077  
  No condom use  2022 64.0%  716 61.1%    
STI diagnosed          
Chlamydia any site  315/3200 9.8%  120/1260 9.5%  0.746  
Pharyngeal  48/3193 1.5%  13/1234 1.1%  0.250  
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Urethral 112/3195 3.5% 32/1252 2.6% 0.101
Anorectal 227/3190 7.1% 93/1209 7.7% 0.511
  Of which LGV 25/188 13.3% 4/74 5.4% 0.173
Gonorrhoea any site 389/3205 12.2% 141/1260 11.1% 0.331
Pharyngeal 201/3194 6.3% 55/1235 4.5% 0.019
Urethral 103/3196 3.2% 39/1255 3.1% 0.844
Anorectal 261/3184 8.2% 103/1210 8.5% 0.735
Syphilis d 102/3197 3.2% 57/1258 4.5% 0.030
Any bacterial STI e 713/3196 22.3% 270/1258 21.4% 0.540
New HIV diagnosis 21/2571 0.8% 11/1143 1.0% 0.658
Drug use during sex c 
Alcohol 1372 42.9% 360 28.6% <0.001
Amphetamine 159 5.0% 32 2.5% <0.001
Cannabis 405 12.7% 107 8.5% <0.001
Cocaine 386 12.1% 57 4.5% <0.001
GHB/GBL 565 17.7% 128 10.2% <0.001
Ketamine 208 6.5% 30 2.4% <0.001
Nitrites 618 19.3% 105 8.3% <0.001
Mephedrone 60 1.9% 6 0.5% <0.001
Methylamfetamine 100 3.1% 10 0.8% <0.001
XTC 647 20.2% 178 14.1% <0.001
Other 59 1.8% 18 1.4% 0.338
Number of different drugs used f <0.001
  0 1285 40.1% 731 58.0%
  1 724 22.6% 258 20.5%
  2 488 15.3% 152 12.1%
  3 334 10.4% 65 5.2%
  4 163 5.1% 27 2.1%
  ≥5 207 6.5% 27 2.1%
# GGD Den Haag, Flevoland, Hollands Noorden and region Utrecht a 373 missing, b does not includes new diag-
noses, c in the past 6 months, d includes all stadia, e includes chlamydia, gonorrhoea and syphilis diagnoses, f 
includes alcohol
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Figure 1A: Patterns of drugs use among 3201 men who have sex with men having an STI consultation 
at the STI clinic of Amsterdam.  
• The overall percentage of specific drug use among MSM in all clusters.
Bars indicate proportion of MSM within a cluster who use a specific drug. Darker bars represent
distinguishing characteristics of the cluster.
Clusters 1 “No drugs”; Cluster 2 “Alcohol”; Cluster 3 “Alcohol + soft drugs”; Cluster 4 “XTC+GHB+Alcohol”; Cluster 5 
“Polydrug” 
Figure 1B: Correlation networks between drugs 
when used during sex in Amsterdam.  
Positive and negative correlations of all MSM (inde-
pendent of clusters) are depicted in red and blue, 
respectively. Stronger correlations have thicker lines 
and colored shading. 
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Figure 2A: Patterns of drugs use among 1260 men who have sex with men having an STI consultation 
at the STI clinic in the surrounding urban regions of Amsterdam.  
• The overall percentage of specific drug use among MSM in all clusters.
Bars indicate proportion of MSM within a cluster who use a specific drug. Darker bars represent
distinguishing characteristics of the cluster.
Clusters 1 “No drugs”; Cluster 2 “Alcohol”; Cluster 3 “Polydrug and poppers”; Cluster 4 “GHB+XTC”
Figure 2B: Correlation networks between drugs when used dur-
ing sex in surrounding urban regions of Amsterdam.  
Positive and negative correlations of all MSM (independent of 
clusters) are depicted in red and blue, respectively. Stronger 
correlations have thicker lines and colored shading. 
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Cluster 3  
N=469 
Alcohol + soft drugs 
Cluster 4 
 N=380 






N % N % N % N % N % 
SOCIO-DEMOGRAPHIC CHARACTERISTICS 
Age in years <0.001 
Median [IQR] 38 [29-49] 31 [26-41] 37 [28-47] 36 [28-46] 40 [30-49] 
Ethnicity 0.005 
Dutch 640 49.7% 418 57.1% 243 51.8% 213 56.1% 207 62.2% 
Turkey/Morocco 56 4.4% 27 3.7% 14 3.0% 14 3.7% 6 1.8% 
Dutch Antilles 106 8.3% 38 5.2% 24 5.1% 31 8.2% 15 4.5% 
Eastern Europe 41 3.2% 28 3.8% 20 4.3% 12 3.2% 7 2.1% 
Sub Saharan Africa 27 2.1% 13 1.8% 12 2.6% 5 1.3% 3 0.9% 
Middle & South America 73 5.7% 35 4.8% 37 7.9% 21 5.5% 16 4.8% 
Asia 127 9.9% 57 7.8% 33 7.0% 36 9.5% 31 9.3% 
Western other 214 16.7% 113 15.5% 86 18.3% 48 12.6% 48 14.4% 
Educational level a 0.059 
Low & Middle 388 33.6% 190 29.0% 119 27.7% 113 32.8% 87 27.7% 
High 768 66.4% 465 71.0% 311 72.3% 232 67.3% 227 72.3% 
HIV status b <0.001 
Positive 217 16.9% 87 11.9% 106 22.6% 86 22.6% 112 33.6% 
Reason of consultation 
  Partner notification 276 21.5% 162 22.1% 94 20.0% 104 27.4% 98 29.4% 0.003 
  STI related symptoms 261 20.3% 167 22.8% 93 19.8% 83 21.8% 81 24.3% 0.373 
SEXUAL BEHAVIOR CHARACTERISTICS in the past 6 months 
Sexual partners <0.001 
Both male and female partners 91 7.1% 92 12.6% 31 6.6% 43 11.3% 10 3.0% 
Condom use during last sex act <0.001 
No condom use/condom failure 757 59.9% 446 62.0% 285 61.2% 278 73.9% 253 76.7% 
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Number of sex partners            <0.001 
Median [IQR] 5 [3-10] 6 [3-10] 10 [6-20] 10 [5-18] 15 [6-30]  
SEXUALLY TRANSMITTED INFECTIONS (STI) 
   Chlamydia any site 127 9.9% 63 8.6% 44 9.4% 40 10.5% 41 12.3% 0.425 
  Pharyngeal 17 1.3% 7 1.0% 11 2.4% 5 1.3% 8 2.4% 0.208 
  Urethral 45 3.5% 29 4.0% 9 1.9% 18 4.8% 11 3.3% 0.220 
  Anorectal 87 6.8% 45 6.2% 36 7.7% 29 7.7% 30 9.0% 0.486 
     Of which LGV 11/75 14.7% 4/35 11.4% 6/31 19.4% 2/19 10.5% 2/28 7.1% 0.688 
Gonorrhea any site 125 9.7% 84 11.5% 63 13.4% 59 15.5% 58 17.4% <0.001 
  Pharyngeal 61 4.8% 49 6.7% 25 5.3% 30 7.9% 36 10.8% 0.001 
  Urethral 38 3.0% 20 2.7% 20 4.3% 13 3.4% 12 3.6% 0.605 
  Anorectal 79 6.2% 48 6.6% 46 9.8% 42 11.1% 46 13.9% <0.001 
Syphilis 46 3.6% 17 2.3% 17 3.6% 15 4.0% 7 2.1% 0.322 
Primary/secondary/recent 34 2.6% 14 1.9% 16 3.4% 13 3.4% 7 2.1% 0.421 
Latens tarda/unknown stadium 12 0.9% 3 0.4% 1 0.2% 2 0.5% 0 0% 0.174 
Any bacterial STI 265 20.6% 148 20.3% 108 23.1% 101 26.6% 91 27.3% 0.012 
Any bacterial STI adjustedd  21.5%  19.7%  22.6%  25.8%  26.4%  
New HIV diagnosis 9/1056 0.9% 5/641 0.8% 4/360 1.1% 1/293 0.3% 2/221 0.9% 0.870 
a 304 missing, b does not includes new diagnoses, c was not used when making clusters, d adjusted for age, ethinicity (dutch vs non-dutch) and HIV status, using multinominol logistic regres-
sion analysis. Abbreviations: MSM, Man who have sex with men; IQR, Inter quartile ranges; STI, sexually transmitted infection; GHB, γ-hydroxybutyrate; GBL, γ- butyrolactone; XTC, ec-
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Table 3. Characteristics of 4 clusters among 1271 MSM attending STI clinics in the surrounding urban regions of Amsterdam.  
 








Polydrug and Poppers 
Cluster 4 
 N=128 
GHB + XTC 
 
P-value  
 N % N % N % N %  
SOCIO-DEMOGRAPHIC CHARACTERISTICS   
Age in years         <0.001 
Median [IQR] 36 [26-49] 28 [23-35] 35 [25-46] 41 [29-52]  
Ethnicity         0.205 
Dutch 459 62.9% 195 63.7% 65 69.2% 98 76.6%  
Turkey/Morocco 23 3.2% 16 5.2% 4 4.3% 3. 2.3%  
Dutch Antilles 67 9.2% 23 7.5% 1 1.1% 8 6.3%  
Eastern Europe 18 2.5% 8 2.6% 3 3.2% 2 1.6%  
Sub Saharan Africa 17 2.3% 4 1.3% 0 0% 1 0.8%  
Middle & South America 20 2.7% 10 3.3% 2 2.1% 2 1.6%  
Asia 60 8.2% 20 6.5% 11 11.7% 8 6.3%  
Western other 66 9.0% 30 9.8% 8 8.5% 6 4.7%  
Educational level a         0.008 
Low & Middle 302 44.1% 129 44.2% 46 51.7% 73 59.8%  
High 383 55.9% 163 55.8% 43 48.3% 49 40.2%  
HIV status b         <0.001 
Positive 46 6.3% 22 7.2% 15 16.0% 22 17.2%  
Reason of consultation          
  Partner notification 138 18.9% 47 15.4% 13 13.8% 37 28.9% 0.006 
  STI related symptoms 108 14.8% 63 20.6% 14 14.9% 19 14.8% 0.124 
SEXUAL BEHAVIOR CHARACTERISTICS in the past 6 months 
Sexual partners         <0.001 
Both male and female partners 120 16.4% 86 28.1% 16 17.0% 30 23.4%  
Condom use during last sex act         0.001 
No condom use/condom failure 411 60.4% 164 57.3% 47 55.3% 94 77.7%  
Number of sex partners          <0.001 
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Median [IQR] 4 [3-8] 5 [3-8] 8 [4-15] 10 [5-15]  
DRUG USE DURING SEX
 
(6m) 
Other c 3.9% 1 5 1.6% 7 7.5% 5 3.9% <0.001 
Median number of drugs used 
[IQR] 
[1-3] 0 1 [1-2] 2 [2-4] 2 [1-3] <0.001 
SEXUALLY TRANSMITTED INFECTIONS (STI) 
   Chlamydia any site 59 8.1% 30 9.8% 9 9.6% 22 17.2% 0.014 
  Pharyngeal 6 0.8% 2 0.7% 1 1.1% 4 3.2% 0.103 
  Urethral 20 2.7% 6 2.0% 0 0% 6 4.7% 0.154 
  Anorectal 42 6.0% 25 8.6% 8 8.6% 18 14.3% 0.012 
     Of which LGV 0/32 0% 2/19 10.5% 1/7 14.3% 1/16 6.3% 0.272 
Gonorrhea any site 66 9.0% 33 10.8% 14 14.9% 27 21.1% 0.001 
  Pharyngeal 26 3.6% 9 3.0% 9 9.6% 11 8.7% 0.003 
  Urethral 19 2.6% 8 2.6% 2 2.1% 10 7.9% 0.013 
  Anorectal 48 6.9% 24 8.3% 10 10.8% 21 16.7% 0.003 
Syphilis 35 4.8% 12 3.9% 7 7.5% 3 2.4% 0.308 
Primary/secondary/recent 22 3.0% 10 3.3% 6 6.4% 3 2.3% 0.333 
Latens tarda/unknown stadium 13 1.8% 2 0.7% 1 1.1% 0 0% 0.252 
Any bacterial STI 137 18.7% 62 20.3% 25 26.6% 46 36.2% <0.001 
Any bacterial STI adjusted d  19.2%  19.4%  25.7%  35.8%  
New HIV diagnosis 3 0.4% 3 1.1% 1 1.3% 4 3.8% 0.013 
a 74 missing, b does not includes new diagnoses, c was not used when making clusters, d adjusted for age, ethinicity (dutch vs non-dutch) and HIV status, using multinominol logistic regres-
sion analysis. Abbreviations: MSM, Man who have sex with men; IQR, Inter quartile ranges; STI, sexually transmitted infection; GHB, γ-hydroxybutyrate; GBL, γ- butyrolactone; XTC, 
ecstasy; MDMA, 3,4-Methylenedioxymethamphetamine. 
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Supplemental figures 
Figure 1a (appendix): Prevalence of STI per cluster adjusted for age, ethnicity and HIV-status among 
3207 MSM attending the STI clinic in Amsterdam. 
Red= crude prevalence 
Black = adjusted prevalence 
Figure 1b (appendix): Prevalence of STI per cluster adjusted for age, ethnicity and HIV-status among 
3207 MSM attending STI clinics in surrounding urban regions. 
Red= crude prevalence 
Black = adjusted prevalence 
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